- Home
- PET vs KTTA Comparison
PET vs KTTA Comparison
Compare PET & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- KTTA
- Stock Information
- Founded
- PET 2015
- KTTA 2020
- Country
- PET United States
- KTTA United States
- Employees
- PET N/A
- KTTA N/A
- Industry
- PET EDP Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- PET Technology
- KTTA Health Care
- Exchange
- PET Nasdaq
- KTTA Nasdaq
- Market Cap
- PET 5.9M
- KTTA 2.8M
- IPO Year
- PET N/A
- KTTA 2021
- Fundamental
- Price
- PET $0.16
- KTTA $0.73
- Analyst Decision
- PET Strong Buy
- KTTA
- Analyst Count
- PET 3
- KTTA 0
- Target Price
- PET $4.17
- KTTA N/A
- AVG Volume (30 Days)
- PET 11.3M
- KTTA 201.2K
- Earning Date
- PET 08-06-2025
- KTTA 08-12-2025
- Dividend Yield
- PET N/A
- KTTA N/A
- EPS Growth
- PET N/A
- KTTA N/A
- EPS
- PET N/A
- KTTA N/A
- Revenue
- PET $62,453,000.00
- KTTA N/A
- Revenue This Year
- PET $7.87
- KTTA N/A
- Revenue Next Year
- PET $122.23
- KTTA N/A
- P/E Ratio
- PET N/A
- KTTA N/A
- Revenue Growth
- PET N/A
- KTTA N/A
- 52 Week Low
- PET $0.08
- KTTA $0.70
- 52 Week High
- PET $1.69
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- PET 57.81
- KTTA 35.89
- Support Level
- PET $0.10
- KTTA $0.70
- Resistance Level
- PET $0.26
- KTTA $0.76
- Average True Range (ATR)
- PET 0.03
- KTTA 0.04
- MACD
- PET 0.01
- KTTA 0.01
- Stochastic Oscillator
- PET 51.95
- KTTA 16.63
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).